相似文献
1
Emergence of KPC-producing Pseudomonas aeruginosa in Trinidad and Tobago.
J Clin Microbiol. 2009 Aug;47(8):2670-1. doi: 10.1128/JCM.00362-09. Epub 2009 Jun 3.
2
A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase.
J Antimicrob Chemother. 2006 Jun;57(6):1261-2. doi: 10.1093/jac/dkl116. Epub 2006 Apr 14.
3
Prevalence and molecular characterisation of metallo-beta-lactamase producing strains of imipenem-resistant Pseudomonas aeruginosa in Turkey.
Indian J Med Microbiol. 2014 Jul-Sep;32(3):349-50. doi: 10.4103/0255-0857.136622.
4
First report of KPC-producing Pseudomonas aeruginosa in Brazil.
Antimicrob Agents Chemother. 2012 Sep;56(9):4990. doi: 10.1128/AAC.00699-12. Epub 2012 Jul 2.
5
First clonal spread of KPC-producing Pseudomonas aeruginosa in Buenos Aires, Argentina.
Infect Genet Evol. 2012 Dec;12(8):2003-5. doi: 10.1016/j.meegid.2012.03.022. Epub 2012 Apr 5.
6
Detection of a new extended-spectrum oxacillinase in Pseudomonas aeruginosa.
J Antimicrob Chemother. 2010 Feb;65(2):364-5. doi: 10.1093/jac/dkp438. Epub 2009 Dec 11.
7
Regional spread of Pseudomonas aeruginosa ST357 producing IMP-7 metallo-β-lactamase in Central Europe.
J Clin Microbiol. 2011 Jan;49(1):474-5. doi: 10.1128/JCM.00684-10. Epub 2010 Oct 27.
8
First report of a Pseudomonas aeruginosa clinical isolate co-harbouring KPC-2 and IMP-18 carbapenemases.
Int J Antimicrob Agents. 2012 Jun;39(6):542-3. doi: 10.1016/j.ijantimicag.2012.02.009. Epub 2012 Apr 20.
9
First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States.
Antimicrob Agents Chemother. 2005 Aug;49(8):3538-40. doi: 10.1128/AAC.49.8.3538-3540.2005.
10
Molecular characterization of metallo-β-lactamase-producing Pseudomonas aeruginosa in a Czech hospital (2009-2011).
J Med Microbiol. 2013 Jun;62(Pt 6):945-947. doi: 10.1099/jmm.0.056119-0. Epub 2013 Mar 14.
引用本文的文献
1
Antimicrobial resistance and carbapenemase dissemination in isolates from Libyan hospitals: a call for surveillance and intervention.
Libyan J Med. 2024 Dec 31;19(1):2344320. doi: 10.1080/19932820.2024.2344320. Epub 2024 Apr 21.
2
Worldwide Dissemination of Gene by Novel Mobilization Platforms in : A Systematic Review.
Antibiotics (Basel). 2023 Mar 28;12(4):658. doi: 10.3390/antibiotics12040658.
3
Emerging and re-emerging KPC-producing hypervirulent ST697 and ST463 between 2010 and 2021.
Emerg Microbes Infect. 2022 Dec;11(1):2735-2745. doi: 10.1080/22221751.2022.2140609.
4
Acquisition of resistance to ceftazidime-avibactam during infection treatment in through D179Y mutation in one of two gene copies without losing carbapenem resistance.
Front Cell Infect Microbiol. 2022 Sep 2;12:981792. doi: 10.3389/fcimb.2022.981792. eCollection 2022.
5
Characterization of -Carrying Plasmid pR31-KPC from a Strain Isolated in China.
Antibiotics (Basel). 2021 Oct 11;10(10):1234. doi: 10.3390/antibiotics10101234.
6
Extended Spectrum Beta-Lactamase (ESBL) Produced by Gram-Negative Bacteria in Trinidad and Tobago.
Int J Microbiol. 2021 Aug 23;2021:5582755. doi: 10.1155/2021/5582755. eCollection 2021.
7
Mobile Carbapenemase Genes in .
Front Microbiol. 2021 Feb 18;12:614058. doi: 10.3389/fmicb.2021.614058. eCollection 2021.
8
Phenotypic and Genotypic Features of Harboring Carbapenemases in Egypt: OXA-48-Like Carbapenemases as an Investigated Model.
Antibiotics (Basel). 2020 Nov 28;9(12):852. doi: 10.3390/antibiotics9120852.
9
Coharboring and Carbapenemase Genes.
Antibiotics (Basel). 2019 Jul 20;8(3):98. doi: 10.3390/antibiotics8030098.
10
Genome plasticity favours double chromosomal Tn4401b-bla transposon insertion in the Pseudomonas aeruginosa ST235 clone.
BMC Microbiol. 2019 Feb 20;19(1):45. doi: 10.1186/s12866-019-1418-6.
本文引用的文献
1
Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamases.
Antimicrob Agents Chemother. 2009 Apr;53(4):1660-4. doi: 10.1128/AAC.01172-08. Epub 2009 Feb 2.
2
Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4.
Antimicrob Agents Chemother. 2009 Feb;53(2):557-62. doi: 10.1128/AAC.00734-08. Epub 2008 Nov 17.
3
Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene.
Antimicrob Agents Chemother. 2008 Apr;52(4):1257-63. doi: 10.1128/AAC.01451-07. Epub 2008 Jan 28.
4
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.
Antimicrob Agents Chemother. 2008 Feb;52(2):796-7. doi: 10.1128/AAC.01180-07. Epub 2007 Dec 3.
5
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.
J Antimicrob Chemother. 2007 Dec;60(6):1206-15. doi: 10.1093/jac/dkm357. Epub 2007 Sep 17.
6
Carbapenemases: the versatile beta-lactamases.
Clin Microbiol Rev. 2007 Jul;20(3):440-58, table of contents. doi: 10.1128/CMR.00001-07.
7
Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
Antimicrob Agents Chemother. 2007 Aug;51(8):3026-9. doi: 10.1128/AAC.00299-07. Epub 2007 Jun 11.
8
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.
Antimicrob Agents Chemother. 2007 Apr;51(4):1553-5. doi: 10.1128/AAC.01405-06. Epub 2007 Jan 29.
9
Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China.
Antimicrob Agents Chemother. 2007 Feb;51(2):763-5. doi: 10.1128/AAC.01053-06. Epub 2006 Dec 4.
10
First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America.
Antimicrob Agents Chemother. 2006 Aug;50(8):2880-2. doi: 10.1128/AAC.00186-06.
Zotero 插件